| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| MRNA | Stock | Healthcare | US$ 58.11 B | 4,89% | |
| NTRA | Stock | Healthcare | US$ 59.15 B | 2,27% | |
| ILMN | Stock | Healthcare | US$ 41.23 B | 2,05% | |
| GEN | Stock | Other | US$ 18.35 B | 1,73% | |
| IQV | Stock | Healthcare | US$ 43.80 B | 1,73% | |
| RVTY | Stock | Healthcare | US$ 14.53 B | 1,71% | |
| GH | Stock | Healthcare | US$ 23.86 B | 1,66% | |
| A | Stock | Healthcare | US$ 42.54 B | 1,52% | |
Roivant Sciences Ltd
|
ROIV | Stock | Healthcare | US$ 25.80 B | 1,51% |
Celltrion Inc
|
068270 | Stock | Healthcare | US$ 41.64 T | 1,49% |
| MRK | Stock | Healthcare | US$ 370.89 B | 1,49% | |
| MEDP | Stock | Healthcare | US$ 16.73 B | 1,46% | |
| AMGN | Stock | Healthcare | US$ 240.11 B | 1,46% | |
| GILD | Stock | Healthcare | US$ 187.51 B | 1,45% | |
| ABBV | Stock | Healthcare | US$ 459.82 B | 1,42% | |
Charles River Laboratories
|
CRL | Stock | Healthcare | US$ 14.13 B | 1,42% |
| DHR | Stock | Healthcare | US$ 148.35 B | 1,39% | |
| BIIB | Stock | Healthcare | US$ 32.63 B | 1,38% | |
| DXCM | Stock | Healthcare | US$ 33.17 B | 1,36% | |
| PFE | Stock | Healthcare | US$ 164.21 B | 1,35% | |
| EXEL | Stock | Healthcare | US$ 14.47 B | 1,35% | |
| JNJ | Stock | Healthcare | US$ 663.28 B | 1,35% | |
Lonza Group AG
|
LONN | Stock | Healthcare | US$ 39.50 B | 1,34% |
| ARGX | Stock | Healthcare | US$ 57.16 B | 1,34% | |
| BMY | Stock | Healthcare | US$ 136.49 B | 1,33% | |
| HALO | Stock | Healthcare | US$ 12.47 B | 1,31% | |
| ABT | Stock | Healthcare | US$ 188.69 B | 1,31% | |
| MDT | Stock | Healthcare | US$ 120.46 B | 1,30% | |
|
Shionogi & Co. Ltd.
|
4507 | - | Healthcare | - | 1,29% |
| JAZZ | Stock | Healthcare | US$ 15.30 B | 1,26% | |
Samsung Biologics Co Ltd
|
207940 | Stock | Healthcare | US$ 63.03 T | 1,25% |
| ROP | Stock | Healthcare | US$ 283.89 B | 1,23% | |
| EW | Stock | Healthcare | US$ 51.76 B | 1,20% | |
| NOVN | Stock | Healthcare | US$ 221.13 B | 1,18% | |
| TECH | Stock | Healthcare | US$ 11.36 B | 1,17% | |
| ISRG | Stock | Healthcare | US$ 131.38 B | 1,16% | |
| GSK | Stock | Healthcare | US$ 94.23 B | 1,14% | |
| TWST | Stock | Healthcare | US$ 12.51 B | 1,12% | |
| BSX | Stock | Healthcare | US$ 68.04 B | 1,09% | |
| TXG | Stock | Healthcare | US$ 12.18 B | 1,07% | |
| NBIX | Stock | Healthcare | US$ 14.55 B | 1,05% | |
Orion Oyj B
|
ORNBV | Stock | Healthcare | US$ 11.34 B | 1,03% |
| RGEN | Stock | Healthcare | US$ 10.25 B | 0,96% | |
| ARWR | Stock | Healthcare | US$ 9.07 B | 0,94% | |
| PODD | Stock | Healthcare | US$ 10.23 B | 0,94% | |
|
UCB SA
|
UCB | Stock | Healthcare | US$ 4.11 B | 0,92% |
|
Eisai Co. Ltd.
|
4523 | - | Healthcare | - | 0,92% |
| QGEN | Stock | Healthcare | US$ 9.24 B | 0,91% | |
| TEM | Stock | Healthcare | US$ 13.83 B | 0,85% | |
| PME | Stock | Healthcare | US$ 20.02 B | 0,84% | |
| AXSM | Stock | Healthcare | US$ 10.91 B | 0,82% | |
| ALKS | Stock | Healthcare | US$ 7.73 B | 0,81% | |
|
Shimadzu Corp
|
7701 | - | Technology | - | 0,77% |
Average Investor10 user rating
4.0
(0 people)
iShares Healthcare Innovation UCITS ETF USD (Acc) GBP (Ireland) is an exchange-traded fund (ETF), with assets under management totaling $994.81 million.
Over the past 12 months, iShares Healthcare Innovation UCITS ETF USD (Acc) GBP recorded a return of 26.18%, with its price trading between $0.12 and $11.02 during the same period.
The ETF is traded under the ticker DRDR.
The current price of DRDR is $10.70. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
DRDR is currently trading at $10.70, with a market capitalization of approximately $994.810.000,00. Over the past year, the ETF has delivered a 26.18% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in DRDR through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol DRDR, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, DRDR has returned 1.90%, and 26.18% over the past year.
If you were to purchase 100 shares of DRDR at the current price of $10.70, your total investment would be $1,070.00.
After 1 month the profitability would be $1,090.33.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
